stanozolol has been researched along with Cancer of Gastrointestinal Tract in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blamey, SL; Carter, DC; Douglas, JT; Forbes, CD; Lowe, GD | 1 |
1 trial(s) available for stanozolol and Cancer of Gastrointestinal Tract
Article | Year |
---|---|
Plasma beta-thromboglobulin, fibrinopeptide A and B beta 15-42 antigen in relation to postoperative DVT, malignancy and stanozolol treatment.
Topics: Beta-Globulins; beta-Thromboglobulin; Clinical Trials as Topic; Double-Blind Method; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Humans; Peptide Fragments; Postoperative Complications; Stanozolol; Thrombophlebitis | 1985 |